MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.medcli.2024.05.002

Медицинская библиотека · Medicina clinica · 2024

Neuropsychiatric symptoms of patients two years after experiencing severe COVID-19: A mixed observational study.

Meca-García José Miguel, Perní-Lasala María Teresa, Parrón-Carreño Tesifón, Lozano-Paniagua David, Castro-Luna Gracia, Nievas-Soriano Bruno José

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

The impact of SARS-CoV-2 infection (COVID-19) on mental health has not been extensively studied in the medium and long term. This study assessed how clinical, biological, and social factors affect mental health in patients who recovered from severe COVID-19. The evaluation was done 90 days after hospital discharge and followed up at 12 and 24 months.

METHODS

A retrospective-prospective cohort mixed observational study was conducted on patients over 18 years of age who required hospitalization in Internal Medicine or ICU for severe COVID-19 pneumonia during 2020 and 2021. Demographic information, clinical variables, and data for the scales were obtained from electronic medical records and telephone interviews. For comparisons of the different variables in each clinical variable (insomnia, depression, anxiety), the Student's t-test for independent samples has been used (normal distribution); otherwise, the Mann-Whitney test will be used. All tests and intervals will be performed with a confidence level of 95. Fisher's exact or Pearson's Chi-square test has been used as appropriate for qualitative variables.

RESULTS

201 patients were recruited. 37.3% presented insomnia, 22.4% anxiety, and 21.4% depressive symptoms. A direct association was established between female sex and depressive symptoms. Psychotropic history, fatigue, and C-reactive protein levels (CRP) were correlated with depression. Anosmia and ageusia, CRP, cognitive symptoms, and dyspnea predicted insomnia. Sex, orotracheal intubation (OTI), pain, fatigue, mental health history, and academic level were independent predictors of anxiety. High percentages of depressive, anxiety, and insomnia symptoms were detected in the second month after discharge and persisted at 12 and 24 months. The fatigue variable maintained a significant relationship with depressive symptoms at 2, 12 and 24 months. A possible limitation could be recall bias in retrospective data collection.

CONCLUSIONS

This is a novel study to follow up on mental health for two years in patients with severe COVID-19. Clinical, biological, and psychosocial variables could be predictors of depressive symptoms, anxiety, and insomnia. The psychiatric symptoms persisted throughout the 2-year follow-up. These findings are critical for the follow-up of these patients and open the possibility of further studies in the medium and long term.

Для цитирования: Meca-García José Miguel, Perní-Lasala María Teresa, Parrón-Carreño Tesifón, Lozano-Paniagua David, Castro-Luna Gracia, Nievas-Soriano Bruno José. Neuropsychiatric symptoms of patients two years after experiencing severe COVID-19: A mixed observational study.. Medicina clinica. 2024. DOI: 10.1016/j.medcli.2024.05.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.